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Cytotoxic activity of tumor necrosis factor is inhibited by ~rni~~~id~ 
derivatives without involvement of the Na’/H’ a~ti~~rt~~ 
Received 2 January 1990 
Q,%~taxidty of tumor necrosis factor @NF) on L929s cells was et%ientiy bloekd by several amiloride analogs but not by asniknide itself. This 
~r#~tion did not require RNA or ~r~t~~~ synthesis. Na+/H+ anti~~er-~e~t~v~ L-MflK-) cells (LAP) could be killed by TNF, showing that 
the Na*/H* exchanger is not required for ~~~ytota~~ty. Similar prot~t~o~ alit TNF-mediated cefl lysis by arnil~~~~ derivatives was found 
for LAP and L929s ceils, excludinS a blockade of the Na+ jH* antiporter as the cause of the protection against TNF by these agents. 
Tumor necrosis factor; Cytotoxicity; Amiloride; %!a*,%” antiporter; Qtokine 
Tumor necrosis factor (TNF), primarily produced by 
activated macrophages, is selectively cytotoxic for 
many tumor cells. TNF also induces in both transform- 
ed and ~transform~ cells a verity of other biological 
effects, mostly related to ~~~~rnrnatory and im- 
munomodulatory activities [I] 1) 
a Sj~~~ taFget ~~0~ to a number of ~~~~ fac- 
tors fl2], we investigated the role of this antiporter in 
the observed protection. 
2,1. Cell lines and media 
Signaling mechanisms involved in TN&mediated 
cytotoxicity are at present large& unclear. TNF binds to 
its target e&s via high affinity, cell surface-associated 
~~~~~oF$ f&q_ The T~-~~or compIex is subse- 
quently ~~tern~~ by undies, followed by 
degradation of TNF [Z-4]. It is not clear whether this 
internalization and degradation are required for TNF- 
cytatoxicity [5-7f. Post-receptor mechanisms are also 
poorly understood. A partieukr C-protein might be in- 
volved @I]. TNF includes ~r~~~idonic a id release, 
possibly via a phospholipase AZ ;ac~dvation 19,lo]. TNF- 
mediated cytotoxicity does not depend on cellular 
RNA- or protein synthesis [1 11, 
The nnutine L929s fibrosarcoma cell Inns, sensitive to TNP- 
cytotoxicity, was obtained from Dr Konings (Vega Jnstitute, Leuven, 
Belgium). The cell lines L-M(TK-) and its derivative LAP, which is 
de~ofd af functional Na*/H+ ant&or&r, were described previously 
{x3$. Cufture and assay medium for all ceh &tes was DuJ#ecco’s 
~~~~ Eagle”s m&mn, s~~~~~~ with 5% fetaJ c&f sertma, 
5% newborn caJf serum, and an~j~~~~~~ AB &cell ines were 
myco~liv3ma-frt4e, as jui&cl by z5 ~NA-~uo~~rorne assay jf4j. 
Here, we report that several amiloride analogs, bnt 
not an&ride itself, evasively pro&et L929s cells 
agzdnst T~~~~tox~~i~~. Since the am&&de analogs 
tested are potent inhibiturs of the Na’iH+ exchanger, 
TNF used was recombinant murine TNF [X5] fsp, act. of 1.9 X tCts 
i~ter~~tion~ units/mg (determined as in (HQ); international standard 
TNF &ode no. 8U532) was from N~t~a~~~ Biologic Standards 
Board, Henfordshire, UK). Amiloride ~S~~~~) was dissolved in 
culture medium. The amiloride analogs used ware described previous- 
ly [ 17) 1 They were synthesized for this study IS described earlier [ 181. 
Stock solutions were prepared in dimethyl sulfoxide {DMSO) at 100 
nM, For use on &is, these stock solutions were dibned in cuhnre 
n&mm at 37°C such that the final ~~~~~ratjo~ of DMSD never ex- 
ceede# %4%, Control experiments demo~~~ted that swch DMSO 
~~~~~~a~~~~~ h& no =S%S on T~~~~~~~~~~~ The ability of the 
antihrride analogs to btock Na’c”H* a&porter activity was checked 
via their protection of L929s to protora suicide [19J. 
C~~q~~&nce uddiws: W. Fiers, Lsbamtory of Moiecn~ar 
Biology, State University of Crent, Ledeganckstraat 35, 9ooO Gent, 
~~~$~Urn 
2.3. A8rfly for qvtotoxicity 
~~~~~~tia~: ActD, actinomycia D; GHX, ~yc~~he~mide; DMA, 
.%(JV,N-dimethyl)amiloride; DMSO, dimrthyl sulfoxide; EIPA, S-(IV- 
ethyl-N+opropyl)amiloride; HMA, j-IIN,hi-he~ethy~ene)_ami- 
loride; MIBA, S-(N-methyl-N-isobutyl)atmloride; MGCMA, 5-(N- 
me~yl~~~nidinocarbon~lm~h~l))~~oride; MlYF+ 3-f4,5-di- 
metbylthi~~~“2-y~~~ph~ny~t~~~~~m brumide; OD, opticrd den- 
sity; TNF, tumor necrosis fador, U, ~~ts~rn~ 
All assays were performed at 37°C in a humidified fO% 
C~s~~~~bator. Cefls were seeded in %-weEel! act-~ttom mieroweits 
(~~~~~~ Becton Dickinson, NJ) at 2 X l@ cells in 100 pl medium, 
Twelve to 16 h later, 50 ~1 of amiloride (armlog) dihnion was added. 
TNF (with or without metabolic blockers) w&s given 2 h later in a 50 
~1 volume. Metabolic inhibitors used were aetinomyein D (ActD, 1 
~g/ml) or Cycloheximide (CHX, SO&m& After 20 h of further in- 
cubation, Eeli v&i&y was routinely de~~~~ via 3+,5-d% 
m~ayrttti~#~-~-~~~bj~~y~te~~o~~~ bromide @TT) staining 
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[20]. Similar results were observed with crystal violet staining of at- 
tached cells [21] (data not shown). 
3. RESULTS AND DISCUSSION 
The reported [ 171 inhibitory activity of amiloride and 
its derivatives on the Na’/H+ antiporter is shown in 
table 1. Their effect on cytotoxicity, induced in L929s 
cells by a fixed TNF concentration, is also presented in 
table 1. It is clear that amiloride itself is not protective, 
even when tested at higher concentrations (up to 500 
PM, data not shown). In contrast, several amiloride 
analogs showed a potent protection against TNF- 
cytotoxicity. The effect of EIPA, a representative pro- 
tective inhibitor, at different TNF-concentrations is 
shown in fig. 1. Only MGCMA was almost not protec- 
tive at the concentrations hown, although the drug was 
effective in protection of L929s in a proton suicide test 
(data not shown). However, at 200pM MGCMA, con- 
siderable protection was found (results not shown). It is 
known that amiloride and analogs penetrate the cells 
and at elevated concentrations directly inhibit protein 
too 
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Fig. 1. Inhibition of TNF-cytotoxicity on L929c cells by EIPA. 
Percentage survival is plotted against increasing TNF concentrations. 
For each inhibitor concentration, percentage survival is calculated as 
follows: 100 X ODceUJ+TNF+inhibitor/ODeelln. The inSeI% shows the ef- 
fect of different concentrations of EIPA on cell viability in the 
absence of TNF. (0) No inhibitor; (A) 12 r;lM EIPA; (n) 25 PM 
EIPA; (e) 50 CM EIPA; (Y) 100 pM EIPA. 
‘b.07 0.2 0.6 1.9 5.6 16.7 50 150 
U TNF/ml 
Fig. 2. TNF sensitivity of L929s (m), L-M(TK-) (0) and LAP (a) 
cells. TNF sensitivity was determined in a 20 h assay in the presence 
of ActD as described in section 2. Percentage survival is calculated as 
follows: 100 x 0Dce”l+7~~+~eto/ODce~~s+~Et~. Percentagesurvival in 
the presence of ActD alone (referred to 100% = ODceas in cuttun medium 
at0,,c) was 89 f 1,90 f 5 and 96 f 5 for L929s, L-M(TK-) and LAP 
cells, respectively. 
synthesis [22,23]. It is unlikely that such a side-effect ac- 
counts for the protective action of some amiloride 
analogs, as it is well established that inhibition of pro- 
tein synthesis effectively potentiates TNF-cytotoxicity 
[I l]. Moreover, RNA or protein synthesis was not re- 
quired for protection by amiloride derivatives (see table 
1 for results with RNA synthesis inhibitor, ActD; 
similar but not shown results were found with CHX). It 
is clear that the reported inhibitory potential of the 
amiloride analogs for the Na+/H+ antiporter does not 
correlate completely with their concentration-depen- 
dent protective effect on TNF-cytotoxicity. This sug- 
gests that the Na+/H+ antiporter is not the target 
responsible for this protection. To obtain proof of this, 
we tested the effect of amiloride and its derivatives on 
TNF-c~otoxicity towards Na+/H+ antiporter-negative 
L-M(TK) (LAP) cells. Since both the parental L- 
M(TK) cells and LAP cells were found to be resistant 
to TNF alone (up to 3 x 104 IU TNF/ml; data not 
shown), their TNF-sensitivity was tested in the presence 
of ActD. Under these conditions, no difference in TNF- 
sensitivity was found between the L-M(TK-) cell line 
and its Na+/H+ antiporter-negative derivative (50~0 
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Table 1 
% Survivald Relative survival’ 
W) cont.’ 
(rtM) 
L929s LAP L929s LAP 
no TNF 
62 U TNF’ 0.6 U TNF’ no TNF 150 U TNF’ 
- ActD + ActD - ActD + ActD + ActD + ActD - ActD + ActD + ActD 
none - - 100 f 7 90 f 3 21 f 4 17 + 3 
Amil 83.3 100 lOOk 93zt5 18 f 2 20 f 5 
DMA 6.9 100 83 f 5 84 + 5 56 f 4 58 f 6 
50 95 f 4 85 f 3 49 f 5 39 f 5 
25 95 + 4 86 f 7 41 f 2 23 + 5 
12 98 * 7 93 + 8 30 + 5 18 + 3 
MGCMA 1.4 100 96 f 3 86 + 5 27 f 3 30 + 3 
50 97 f 6 86 zt 3 27 + 2 24 f 3 
25 99+5 90*8 27 f 4 20 f 2 
12 104+5 95&8 23 z!z 3 20 * 5 
MIBA 0.44 50 69 + 3 68 ?z 6 45 * 5 69 z! 5 
25 94 f 2 99 k 6 75 * 2 81 + 5 
12 81+2 86+5 45 k 6 33 * 2 
EIPA 0.38 50 90+6 95+9 82 + 4 95 * 4 
25 88+9 90+6 73 * 3 60 * 5 
12 90+6 92zt3 49 + 6 24 * 3 
HMA 0.16 25 80+5 81+9 75 * 2 77 + 5 
12 88*2 90+6 67 + 7 77 + 5 
90 * 8 
80 zt 3 
73 * 5 
86 * 5 
93 * 4 
98 + 2 
89 + 2 
91 * 3 
92 + 5 
100 + 3 
T 
63 + 6 
79 + 5 
39 + 3 
67 + 3 
75 * 2 
35 * 6 
63 f 5 
18 f 4 0.21 0.19 0.20 
15 f 3 0.18 0.22 0.19 
33 f 3 0.67 0.69 0.45 
34 f 3 0.52 0.46 0.40 
29 f 3 0.43 0.27 0.31 
31 f 5 0.31 0.19 0.32 
48 f 2 0.28 0.35 0.54 
39 + 5 0.28 0.28 0.43 
29 + 3 0.27 0.22 0.32 
23 f 6 0.22 0.21 0.23 
T 0.65 1 .Ol T 
58 f 5 0.80 0.82 0.92 
55 + 4 0.56 0.38 0.70 
42 f 5 0.91 1.00 1.08 
51 f 3 0.83 0.67 0.76 
46 f 6 0.54 0.26 0.61 
38 zt 4 0.94 0.95 1.09 
54 * 5 0.76 0.86 0.86 
a Amil = amiloride 
b Apparent K, values of inhibition of the Na+/H+-antiporter, evaluated in the presence of 140 mM extracellular Na’ [24] 
’ Only data obtained with drug concentrations resulting in cell survival higher than 35% in the absence of TNF are shown. Highest concentration of 
drugs tested was 100 PM 
d OD of cells incubated in culture medium alone was taken as 100%. T = toxicity, due to drug alone, gives survival < 35% 
’ In the absence of ActD, higher concentrations of TNF were applied on L929s cells in order to obtain a similar percent survival as in the presence 
of ActD. As LAP cells were found to be less TNF sensitive than the L929s cells (especially at higher TNF concentrations, see fig.2), TNF concentra- 
tions were chosen so that both cell lines showed a similar % survival 
’ For each inhibitor concentration, relative survival is defined as follows: 
0Dec11s I- TNFk itiibitor/ODceIIs k- inhibitor 
value: -2 IU TNF/ml; fig.2), showing that the 
Na+/H+-antiporter is not essential for TNF-cytotoxi- 
city. The relative potency of the amiloride analogs for 
protection of LAP cells against TNF-lysis was similar to 
that for protection of L929s cells, and again not related 
to their reported inhibition efficiency of the Na+/H+ 
antiporter (table 1). These results indicate that the ef- 
fective protection against TNF-cytotoxicity by the 
amiloride analogs is not related to their activity on the 
Na+/H+ exchanger. 
In summary, our results show that the 
Na+/H+-antiporter is not needed for signaling in the 
cytotoxic mechanism of TNF. Protection by amiloride 
analogs against TNF-cytotoxicity almost certainly does 
not act via this antiporter. Experiments are currently 
under way to find the target recognized by these 
amiloride analogs in their effective protection against 
TNF. 
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